This test measures activated partial thromboplastin time (aPTT). It is used to screen for deficiencies of plasma coagulation factors and to monitor patients on heparin therapy. Starting February 1, 2024, samples for this test must be shipped on dry ice.
Hey Practitioners! 
Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.
.svg){kind=small}
.svg){kind=small}
